All Posts

Location: Utrecht, Netherlands Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Multiple sclerosis (progressive form) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Utrecht, Netherlands , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and struc

Clinical Case Observation: Secondary Progressive Multiple Sclerosis (SPMS) Patient: Silvia Baistrocchi, 56 years | Italy Patient Background Silvia Baistrocchi , a 56-year-old woman from Italy, has been living with secondary progressive multiple sclerosis (SPMS) . Over time, the disease course led to advanced motor impairment, generalized muscle weakness, and increasing fatigue. As a result, she became wheelchair-dependent and experienced growing difficulty performing basic da

Clinical Case Observation: Parkinsonism Patient: Franco Bonifazi, 81 years | Italy Patient Background Franco Bonifazi , an 81-year-old man from Italy, was diagnosed with parkinsonism . By early 2025, his condition was associated with pronounced motor rigidity, balance instability, reduced mobility, and emerging cognitive decline. These symptoms significantly affected daily functioning, gait safety, and overall independence. Clinical Approach at BioCells Medical In March 2025,

Clinical Case Observation: Secondary Progressive Multiple Sclerosis (SPMS) Patient: Yulia Sergeeva, 35 years | Bishkek, Kyrgyzstan Patient Background Yulia Sergeeva , a 35-year-old woman from Bishkek, Kyrgyzstan, was diagnosed with multiple sclerosis at the age of 16. From the age of 22, the disease entered a progressive phase, leading to a gradual decline in motor function. By 2020, she had lost the ability to walk and became wheelchair-dependent, with pronounced motor impa

Clinical Case Observation: Spinocerebellar Ataxia Type 1 (SCA1) Patient: Anvar, 31 years | Tashkent, Uzbekistan Patient Background Anvar , a 31-year-old man from Tashkent, Uzbekistan, was diagnosed with hereditary spinocerebellar ataxia type 1 (SCA1) — a progressive neurodegenerative condition with a documented family history, including affected first-degree relatives. At the time of consultation, the condition was associated with gait instability , impaired balance, reduced

Location: Nice, France Program: Global Access — On-Site Regenerative Treatment Patient: Pediatric patient (identity undisclosed) Diagnosis: Autism spectrum disorder (ASD) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Nice, France , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for families seeking advanced medical support while receiving treatment out

Location: Naples, Italy Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Post-ischemic stroke (chronic phase) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Naples, Italy , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and structured supervisi

Location: Barcelona, Spain Program: Global Access — On-Site Regenerative Treatment Patient: Pediatric patient (identity undisclosed) Diagnosis: Autism spectrum disorder (ASD) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Barcelona, Spain , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for families seeking advanced medical support while receiving treat

Location: Lyon, France Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Amyotrophic lateral sclerosis (ALS) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Lyon, France , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and structured supervision

Location: Almaty, Kazakhstan Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Multiple sclerosis (relapsing form) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Almaty, Kazakhstan , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and structured

Location: Milan, Italy Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Parkinson’s disease (mid-stage) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Milan, Italy , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is designed for patients who require advanced medical support but prefer or require treatm

Peptides are short chains of amino acids — natural biological messengers that regulate processes throughout the body, including inflammation, metabolism, regeneration, and neurological function. At BioCells Medical, we use targeted peptide protocols to support the effectiveness of our regenerative programmes — helping the body respond more efficiently to cellular therapy, and enhancing specific functions such as neural recovery, energy metabolism, and immune modulation. 💡 Wh

Electro-Neuro Therapy (ENT) is a non-invasive, personalised neurostimulation method used to reactivate and support damaged or underperforming neural pathways. At BioCells Medical, ENT is applied as part of multi-stage regenerative protocols — especially for patients with movement disorders, neurodegeneration, or developmental conditions. The goal is to enhance brain-body communication, stimulate functional circuits, and support recovery of motor, speech, and behavioural funct

Exosomes are microscopic extracellular vesicles naturally released by cells — carrying proteins, RNA, and signaling molecules that influence how other cells behave. At BioCells Medical, we use purified exosomes as a key component of our regenerative medicine protocols — to support cellular communication, reduce inflammation, and promote healing in neurodegenerative, autoimmune, and chronic conditions. 💡 What are exosomes? Exosomes act as messengers between cells. They delive

At BioCells Medical, we use T-regulatory cells (T-regs) to rebalance the immune system in patients where chronic inflammation, autoimmunity, or neuroimmune dysfunction plays a key role. This therapy supports the body’s own ability to self-regulate and protect neural and systemic function — making it especially valuable in neurodegenerative, autoimmune, and developmental conditions. 💡 What are T-regs? T-regulatory cells (T-regs) are a specialised subset of immune cells respon

At BioCells Medical, stem cell therapy forms the core of our personalised regen erative programmes. By using mesenchymal stem cells (MSCs) — either autologous (from the patient) or allogeneic (from a donor) — we aim to modulate inflammation, promote repair, and restore balance in damaged or dysregulated systems. Our stem cells are cultivated under strict conditions in our certified laboratory in Warsaw. 💡 What are mesenchymal stem cells (MSCs)? MSCs are adult stem cells with

At BioCells Medical, world-class regenerative care doesn’t end at our clinic doors. Thanks to our advanced medical infrastructure and mobile clinical protocols, we offer fully personalised treatment in Warsaw or directly at the patient’s location — anywhere in the world. Whether you live in Europe, the Gulf region, or Central Asia, our doctors are equipped to deliver complex multi-stage therapy with the same level of precision and control — always under medical supervision an